NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun 130021, China.
Key Laboratory of Carcinogenesis and Translational Research, Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Ministry of Education, Beijing 100142, China.
Nutrients. 2022 Dec 22;15(1):48. doi: 10.3390/nu15010048.
Cancer is the second most common cause of death among humans in the world, and the threat that it presents to human health is becoming more and more serious. The mechanisms of cancer development have not yet been fully elucidated, and new therapies are changing with each passing day. Evidence from the literature has validated the finding that the composition and modification of gut microbiota play an important role in the development of many different types of cancer. The results also demonstrate that there is a bidirectional interaction between the gut microbiota and radiotherapy treatments for cancer. In a nutshell, the modifications of the gut microbiota caused by radiotherapy have an effect on tumor radiosensitivity and, as a result, affect the efficacy of radiotherapy and show a certain radiation toxicity, which leads to numerous side effects. What is of new research significance is that the "gut-organ axis" formed by the gut microbiota may be one of the most interesting potential mechanisms, although the relevant research is still very limited. In this review, we combine new insights into the relationship between the gut microbiota, cancer, and radiotherapy. Based on our current comprehensive understanding of this relationship, we give an overview of the new cancer treatments based on the gut microbiota.
癌症是全球人类死亡的第二大主要原因,其对人类健康的威胁变得越来越严重。癌症发展的机制尚未完全阐明,新的治疗方法也在日新月异。文献中的证据已经证实,肠道微生物组的组成和修饰在许多不同类型癌症的发展中起着重要作用。研究结果还表明,肠道微生物组和癌症放疗之间存在双向相互作用。简而言之,放疗引起的肠道微生物组的改变会影响肿瘤对放疗的敏感性,从而影响放疗的疗效,并表现出一定的辐射毒性,导致许多副作用。具有新研究意义的是,由肠道微生物群形成的“肠道-器官轴”可能是最有趣的潜在机制之一,尽管相关研究仍然非常有限。在这篇综述中,我们结合了对肠道微生物群、癌症和放疗之间关系的新见解。基于我们目前对这种关系的全面了解,我们概述了基于肠道微生物群的新癌症治疗方法。